204 related articles for article (PubMed ID: 18197838)
1. Glucagon and hyperglycaemia in diabetes.
Cryer PE
Clin Sci (Lond); 2008 May; 114(9):589-90. PubMed ID: 18197838
[TBL] [Abstract][Full Text] [Related]
2. Glucagon: the effects of its excess and deficiency on insulin action.
Fanelli CG; Porcellati F; Rossetti P; Bolli GB
Nutr Metab Cardiovasc Dis; 2006 Mar; 16 Suppl 1():S28-34. PubMed ID: 16530126
[TBL] [Abstract][Full Text] [Related]
3. Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia.
Gu W; Yan H; Winters KA; Komorowski R; Vonderfecht S; Atangan L; Sivits G; Hill D; Yang J; Bi V; Shen Y; Hu S; Boone T; Lindberg RA; Véniant MM
J Pharmacol Exp Ther; 2009 Dec; 331(3):871-81. PubMed ID: 19720878
[TBL] [Abstract][Full Text] [Related]
4. Islet cell function: alpha and beta cells--partners towards normoglycaemia.
Göke B
Int J Clin Pract Suppl; 2008 Mar; (159):2-7. PubMed ID: 18269435
[TBL] [Abstract][Full Text] [Related]
5. Physiology of glucagon.
Gerich JE
Int Rev Physiol; 1981; 24():243-75. PubMed ID: 7021445
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes.
Cervera A; Wajcberg E; Sriwijitkamol A; Fernandez M; Zuo P; Triplitt C; Musi N; DeFronzo RA; Cersosimo E
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E846-52. PubMed ID: 18334612
[TBL] [Abstract][Full Text] [Related]
7. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
8. The role of glucagon in diabetes.
Unger RH; Orci L
Compr Ther; 1982 Jan; 8(1):53-9. PubMed ID: 7039948
[TBL] [Abstract][Full Text] [Related]
9. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
[TBL] [Abstract][Full Text] [Related]
10. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
[TBL] [Abstract][Full Text] [Related]
11. Maintenance of the postabsorptive plasma glucose concentration: insulin or insulin plus glucagon?
Raju B; Cryer PE
Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E181-6. PubMed ID: 16014355
[TBL] [Abstract][Full Text] [Related]
12. The essential role of glucagon in the pathogenesis of diabetes mellitus.
Unger RH; Orci L
Lancet; 1975 Jan; 1(7897):14-6. PubMed ID: 46337
[TBL] [Abstract][Full Text] [Related]
13. Odyssey between Scylla and Charybdis through storms of carbohydrate metabolism and diabetes: a career retrospective.
Vranic M
Am J Physiol Endocrinol Metab; 2010 Dec; 299(6):E849-67. PubMed ID: 20823450
[TBL] [Abstract][Full Text] [Related]
14. Postprandial triglyceridaemia in men with impaired fasting glucose, impaired glucose tolerance and diabetes.
Oka R; Yagi K; Hifumi S; Miyamoto S; Mabuchi H; Yamagishi M; Takeda Y; Inazu A; Nohara A; Kawashiri M; Kobayashi J
Diabet Med; 2008 Aug; 25(8):1008-10. PubMed ID: 18959620
[No Abstract] [Full Text] [Related]
15. Pancreatic alpha-cell dysfunction in diabetes.
Burcelin R; Knauf C; Cani PD
Diabetes Metab; 2008 Feb; 34 Suppl 2():S49-55. PubMed ID: 18640586
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin and diabetes mellitus: the role of glucagon in diabetic hyperglycemia and glucose intolerance.
Wahren J
Scand J Clin Lab Invest; 1976 Oct; 36(6):497-503. PubMed ID: 1006141
[No Abstract] [Full Text] [Related]
17. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical glucagon release in obese hyperglycemic mice.
Laube H; Fussgänger RD; Pfeiffer EF
Horm Metab Res; 1974 Sep; 6(5):426. PubMed ID: 4418950
[No Abstract] [Full Text] [Related]
19. Metabolic fate of plasma glucose during hyperglycemia in impaired glucose tolerance: evidence for further early defects in the pathogenesis of type 2 diabetes.
Bokhari S; Emerson P; Israelian Z; Gupta A; Meyer C
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E440-4. PubMed ID: 19141691
[TBL] [Abstract][Full Text] [Related]
20. Long-term hyperglucagonaemia induces early metabolic and renal phenotypes of Type 2 diabetes in mice.
Li XC; Liao TD; Zhuo JL
Clin Sci (Lond); 2008 May; 114(9):591-601. PubMed ID: 18028036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
